Capital Guardian Trust’s Bio-Rad Laboratories Class A BIO Stock Holding History

Capital Guardian Trust’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-100	Closed	-$20K	–	240
2017 Q1	$20K	Hold	100	–	–	﹤0.01%	479
2016 Q4	$18K	Hold	100	–	–	﹤0.01%	527
2016 Q3	$16K	Hold	100	–	–	﹤0.01%	530
2016 Q2	$14K	Hold	100	–	–	﹤0.01%	528
2016 Q1	$14K	Hold	100	–	–	﹤0.01%	549
2015 Q4	$14K	Hold	100	–	–	﹤0.01%	544
2015 Q3	$13K	Hold	100	–	–	﹤0.01%	546
2015 Q2	$15K	Hold	100	–	–	﹤0.01%	521
2015 Q1	$14K	Buy	+100	New	+$12.4K	﹤0.01%	554

Other funds holding BIO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Capital Guardian Trust's BIO Position: Q2 2017 in Review

Capital Guardian Trust sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2017, closing a stake of 100 shares — an estimated $20K sold.

Capital Guardian Trust first reported a position in BIO in Q1 2015 and held it in 9 quarters. The position peaked at $20K in Q1 2017. 276 funds tracked by Wall St. Rank hold BIO as of Q2 2017.

Capital Guardian Trust reported no remaining Bio-Rad Laboratories Class A position as of Q2 2017 after selling out during the quarter.
Capital Guardian Trust sold 100 Bio-Rad Laboratories Class A shares in Q2 2017, an estimated $20K.
Capital Guardian Trust first reported a position in Bio-Rad Laboratories Class A in Q1 2015 and held it in 9 quarters.
Capital Guardian Trust's Bio-Rad Laboratories Class A position peaked at $20K in Q1 2017.
276 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2017.

Based on Capital Guardian Trust's 13F filing for Q2 2017, filed 14 Aug 2017.